Anti-Interleukin 17A Monoclonal Antibody Secukinumab Reduces Signs and Symptoms of Psoriatic Arthritis in a 24-Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Author(s):
McInnes, I.; Sieper, J.; Braun, J.; Emery, P.; Heijde, D. van der; Isaacs, J.; Dahmen, G.; Wollenhaupt, J.; Schulze-Koops, H.; Gsteiger, S.; Bertolino, A.; Hueber, W.; Tak, P.P.
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-10-31
Language
English
Is part of
Arthritis and Rheumatism (2011), Vol. 63, no. 10, p. S306-S306
